Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Sign Up to like & getrecommendations! Published in 2022 at "Inorganic chemistry"
DOI: 10.1021/acs.inorgchem.2c01694
Abstract: Although Alzheimer's disease (AD) was first described over a century ago, it remains the leading cause of age-related dementia. Innumerable changes have been linked to the pathology of AD; however, there remains much discord regarding… read more here.
Keywords: pbt2 interacts; amyloid peptide; pathology; pbt2 ... See more keywords
Swine flu snipers, Alzheimer’s drug push and Google’s latest gaming bot
Sign Up to like & getrecommendations! Published in 2019 at "Nature"
DOI: 10.1038/d41586-019-03266-0
Abstract: The latest science news, in brief. The latest science news, in brief. read more here.
Keywords: alzheimer drug; push google; drug push; flu snipers ... See more keywords
Doubts persist for claimed Alzheimer's drug.
Sign Up to like & getrecommendations! Published in 2019 at "Science"
DOI: 10.1126/science.366.6471.1298
Abstract: Last week, Biogen gave its first scientific presentation in defense of its startling claim to have developed the first drug that can change the devastating course of Alzheimer9s disease. At the Clinical Trials on Alzheimer9s… read more here.
Keywords: persist claimed; alzheimer drug; doubts persist; claimed alzheimer ... See more keywords
Report on trial death stokes Alzheimer’s drug fears
Sign Up to like & getrecommendations! Published in 2023 at "Science"
DOI: 10.1126/science.adi2242
Abstract: Description Amyloid-clearing antibody lecanemab faces key FDA hearing in June Amyloid-clearing antibody lecanemab faces key FDA hearing in June read more here.
Keywords: trial death; stokes alzheimer; report trial; death stokes ... See more keywords